EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Estimated impact of the COVID-19 pandemic on the prevalence and treatment of depressive symptoms in Peru: an interrupted time series analysis in 2014–2021

David Villarreal-Zegarra, C Mahony Reátegui-Rivera, Sharlyn Otazú-Alfaro, Gloria Yantas-Alcantara, Percy Soto-Becerra, G J Melendez-Torres

Social Psychiatry and Psychiatric Epidemiology · 2023

DOI: 10.1007/s00127-023-02446-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Social Psychiatry and Psychiatric Epidemiology, 2023. Verfasst von David Villarreal-Zegarra und 5 weiteren Autor:innen. Beteiligte Einrichtung: Escuela de Medicina, Universidad César Vallejo, Trujillo, Peru. davidvillarreal@ipops.pe. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The COVID-19 pandemic increased the burden of mental disorders worldwide. Peru has been one of the countries most affected by COVID-19, however, studies evaluating the medium and long-term consequences of the pandemic on Peruvians’ mental health are recent and represent a new field of study in proliferation. We aimed to estimate the impact of the COVID-19 pandemic on the prevalence and treatment of depressive symptoms using nationally representative surveys in Peru.

Methods

Our study is an analysis of secondary data. We carried out a time series cross-sectional analysis based on the National Demographic and Health Survey of Peru, collected using a complex sampling design. The Patient Health Questionnaire-9 was used to measure mild (5–9 points), moderate (10–14 points), and severe (15 points or more) depressive symptoms. The participants were men and women aged 15 years and older, living in urban and rural areas of all regions of Peru. The main statistical analysis used segmented regression with Newey-West standard errors, taking into account that each year of the evaluation was divided into four measures (quarter measure).

Results

We included 259,516 participants. An average quarterly increase of 0.17% (95% CI 0.03–0.32%) in the prevalence of moderate depressive symptoms was identified after the onset of the COVID-19 pandemic (approximately an increase of 1583 new cases of moderate depressive symptoms by each quarter). The percentage of cases treated for mild depressive symptoms increased quarterly by an average of 0.46% (95% CI 0.20–0.71%) after the onset of the COVID-19 pandemic (approximately an increase of 1242 new cases treated for mild depressive symptoms by each quarter).

Conclusion

In Peru, increases in the prevalence of moderate depressive symptoms and the proportion of cases treated with mild depressive symptoms were found after the COVID-19 pandemic. Therefore, this study is a precedent for future research assessing the prevalence of depressive symptoms and the proportion of cases receiving treatment during the pandemic and post-pandemic years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19MaleHumansFemalePeruInterrupted Time Series AnalysisPrevalencePandemicsCross-Sectional StudiesDepression

Stichwörter der Autor:innen

Depressive symptomsEpidemiologyPrevalencePublic healthTreatments

Autor:innen und Institutionen

  • Escuela de Medicina, Universidad César Vallejo, Trujillo, Peru. davidvillarreal@ipops.pe.
  • Instituto Peruano de Orientación Psicológica, Lima, Peru. davidvillarreal@ipops.pe.
  • Instituto Peruano de Orientación Psicológica, Lima, Peru.
  • Unidad de Telesalud, Universidad Nacional Mayor de San Marcos, Lima, Peru.
  • Universidad Continental, Huancayo, Perú.
  • College of Medicine and Health, University of Exeter, Exeter, UK.

Zitieren

APA

Villarreal-Zegarra, D., Reátegui-Rivera, C. M., Otazú-Alfaro, S., Yantas-Alcantara, G., Soto-Becerra, P., & Melendez-Torres, G. J. (2023). Estimated impact of the COVID-19 pandemic on the prevalence and treatment of depressive symptoms in Peru: an interrupted time series analysis in 2014–2021. Social Psychiatry and Psychiatric Epidemiology. https://doi.org/10.1007/s00127-023-02446-8

Vancouver

Villarreal-Zegarra D, Reátegui-Rivera CM, Otazú-Alfaro S, Yantas-Alcantara G, Soto-Becerra P, Melendez-Torres GJ. Estimated impact of the COVID-19 pandemic on the prevalence and treatment of depressive symptoms in Peru: an interrupted time series analysis in 2014–2021. Social Psychiatry and Psychiatric Epidemiology. 2023. doi:10.1007/s00127-023-02446-8

BibTeX
@article{VillarrealZegarra2023,
  author = {Villarreal-Zegarra, David and Reátegui-Rivera, C Mahony and Otazú-Alfaro, Sharlyn and Yantas-Alcantara, Gloria and Soto-Becerra, Percy and Melendez-Torres, G J},
  title = {Estimated impact of the COVID-19 pandemic on the prevalence and treatment of depressive symptoms in Peru: an interrupted time series analysis in 2014–2021},
  journal = {Social Psychiatry and Psychiatric Epidemiology},
  year = {2023},
  doi = {10.1007/s00127-023-02446-8}
}
Kostenlos starten →